Relative Value Partners Group’s Meridian Bioscience Inc VIVO Stock Holding History

Relative Value Partners Group’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,010	Closed	-$200K	–	268
2022 Q4	$200K	Buy	+6,010	New	+$194K	0.01%	244

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Relative Value Partners Group's VIVO Position: Q1 2023 in Review

Relative Value Partners Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,010 shares — an estimated $200K sold.

Relative Value Partners Group first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $200K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Relative Value Partners Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Relative Value Partners Group sold 6,010 Meridian Bioscience Inc shares in Q1 2023, an estimated $200K.
Relative Value Partners Group first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Relative Value Partners Group's Meridian Bioscience Inc position peaked at $200K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Relative Value Partners Group's 13F filing for Q1 2023, filed 12 May 2023.